99 related articles for article (PubMed ID: 1585235)
1. [Nitrates as antiplatelet agents].
De Caterina R; Blanco A
Sangre (Barc); 1992 Feb; 37(1):31-8. PubMed ID: 1585235
[No Abstract] [Full Text] [Related]
2. Vasodilator therapy: interaction of nitrates with angiotensin-converting enzyme inhibitors.
Juggi JS; Koenig-Berard E; Vitou P
Can J Cardiol; 1991 Nov; 7(9):419-25. PubMed ID: 1756422
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet of vasorelaxing actions of some benzylisoquinoline and phenanthrene alkaloids.
Chen KS; Ko FN; Teng CM; Wu YC
J Nat Prod; 1996 May; 59(5):531-4. PubMed ID: 8778245
[TBL] [Abstract][Full Text] [Related]
4. [Molecular mechanism of tolerance for vasodilator nitrates].
Popescu LM; Hinescu ME; Constantinescu S; Tigaret CM; Cinteză M; Gherasim L
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(2):145-54. PubMed ID: 2908076
[No Abstract] [Full Text] [Related]
5. [Nitrates as thrombocyte function inhibitors].
De Caterina R
Z Kardiol; 1994 Jul; 83(7):463-73. PubMed ID: 7941647
[TBL] [Abstract][Full Text] [Related]
6. The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders.
Stamler JS; Loscalzo J
J Am Coll Cardiol; 1991 Nov; 18(6):1529-36. PubMed ID: 1939957
[TBL] [Abstract][Full Text] [Related]
7. [Antiplatelet effects of nitrate derivatives].
De Caterina R
G Ital Cardiol; 1991 May; 21(5):529-41. PubMed ID: 1936757
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.
Gerzer R; Drummer C; Karrenbrock B; Heim JM
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S115-9. PubMed ID: 2484688
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide and regulation of vascular tone: pharmacological and physiological considerations.
McHugh J; Cheek DJ
Am J Crit Care; 1998 Mar; 7(2):131-40; quiz 141-2. PubMed ID: 9509227
[TBL] [Abstract][Full Text] [Related]
10. NO-glibenclamide derivatives: prototypes of a new class of nitric oxide-releasing anti-diabetic drugs.
Calderone V; Rapposelli S; Martelli A; Digiacomo M; Testai L; Torri S; Marchetti P; Breschi MC; Balsamo A
Bioorg Med Chem; 2009 Aug; 17(15):5426-32. PubMed ID: 19595600
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of action of nitrovasodilators].
Castillo Henkel C; Hernández Hernández D; Castillo Henkel E; Valencia Hernández I; Chong EH
Arch Inst Cardiol Mex; 1994; 64(3):291-7. PubMed ID: 7979821
[No Abstract] [Full Text] [Related]
12. [Chinese expert consensus document on the organic nitrates in cardiovascular disease].
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):770-4. PubMed ID: 21092641
[No Abstract] [Full Text] [Related]
13. [The mechanism of action of organic nitrates].
Götz R
Pharm Unserer Zeit; 2003; 32(1):9. PubMed ID: 12577754
[No Abstract] [Full Text] [Related]
14. [Calcium inhibitors, nitrate derivatives. Principles and indications of use].
Macquin-Mavier I; Montagne O
Rev Prat; 1999 Oct; 49(16):1819-23. PubMed ID: 10578615
[No Abstract] [Full Text] [Related]
15. Organic nitrate esters: clinical use and mechanisms of actions.
Ahlner J; Andersson RG; Torfgård K; Axelsson KL
Pharmacol Rev; 1991 Sep; 43(3):351-423. PubMed ID: 1956955
[No Abstract] [Full Text] [Related]
16. [Update on the treatment with nitrates in ischemic cardiopathy].
Lanza GA; Maseri A
Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):187-90. PubMed ID: 12497905
[No Abstract] [Full Text] [Related]
17. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
[TBL] [Abstract][Full Text] [Related]
18. Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: an overview.
Taira N
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S1-9. PubMed ID: 2447414
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of nitrate tolerance].
Maire R; Hess OM; Krayenbühl HP
Schweiz Rundsch Med Prax; 1987 Apr; 76(18):480-4. PubMed ID: 3589306
[No Abstract] [Full Text] [Related]
20. [Pharmacology of nitrates].
Tamargo Menendez J; Delpón E
Ann Cardiol Angeiol (Paris); 1997; 46(7):380-90. PubMed ID: 9452771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
